Colleen Hall

Evidence shows that pharmacists can help drive consumer decisions.

President Trump today called for "tougher negotiation, more competition, and much lower prices at the pharmacy counter," in a statement on lowering drug prices.

President Trump today called for "tougher negotiation, more competition, and much lower prices at the pharmacy counter," in a statement on lowering drug prices.

The President also noted he has directed officials to take actions to end what he termed "global freeloading," which he explained as lowered prices on drugs in other countries compared with the United States, where much of the investment funds for medical research originate.

Following NDPP guidelines for early prevention programs, The Kroger Co. established patient-centered processed that involved collecting and assessing patient records, while connecting those enrolled in the study with lifestyle coaches.

Pharmacists can help consumers make decisions on the best OTC options.

Safe and effective treatments for invasive aspergillosis and invasive mucormycosis are vital to patients with cancer to reduce morbidity and mortality.

The development of mold-active azoles has led to enormous advancements in both prevention and treatment of invasive fungal infections.

Pharmacy professionals must embrace a number of changes in technology.

Dr. Baird said that it is important for pharmacy professionals to embrace these changes in technology, and he offered some advice for how to go about embracing the changes.

ASHP officials took time to recognize some of their own.

Community pharmacists are central to public health emergency planning and response efforts.

The candidate vaccine is a nonlive, recombinant subunit vaccine to help prevent herpes zoster and its complications, such as postherpetic neuralgia, in adults 50 and older.

Lifestyle management plans for lowering blood pressure are also highlighted in the guidelines and include suggestions on weight loss, nutrition, and increased physical activity.

New fluoroquinolone provides options for serious skin infection treatment.

These data, from the integrated analysis of the CANVAS and CANVAS-R trials, demonstrated the CV safety of canagliflozin (P

Opana ER was first approved in 2006 for the management of moderate-to-severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

This is the first time the agency has taken steps to remove a currently marketed opioid pain medication from sale due to the public health consequences of abuse

Pharmacists may find themselves in an ethical dilemma related to prescribing of opioids.

Here are some sessions to watch for in our coverage at this year’s meeting.

As part of an ongoing review of fluoroquinolone antibiotics, FDA is informing the public that patient cases identified by the FDA and findings from published studies currently do not support reports that these medicines may result in detachment of the retina in the eyes, or bulges or tears in the aorta blood vessel.

Consumers feeling overloaded by DTC pharmaceutical ads.

Pharmacists can address barriers to treatment, engage with patients, and advocate for change at the community and federal levels.

Advocacy, patient feedback encouraged during APhA keynote address.

Public perceptions on naloxone may differ by community.

APhA is about to kick off and we'll be there all weekend covering it live!

Dr Gottlieb, who has written in various newspapers and other media about the need to expedite drug approvals, falls in line with President Trump’s criticism of the current FDA regulatory process.

Odactra is a once-daily tablet that exposes patients to house dust mite allergens, gradually training the immune system to reduce the frequency and severity of nasal and eye allergy symptoms.

Gilead faces competition from dolutegravir, which is already approved by the Food and Drug Administration.